Methods of prognosis and treatment
US-12228579-B2 · Feb 18, 2025 · US
DNA encoding canine monomeric CRP and expression vector containing the DNA
US9359416B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9359416-B2 |
| Application number | US-201414487513-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 16, 2014 |
| Priority date | Jun 11, 2010 |
| Publication date | Jun 7, 2016 |
| Grant date | Jun 7, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Pentameric CRP is produced at a high efficiency by transferring DNA, which encodes monomeric CRP, into a silkworm to thereby construct a transgenic silkworm and then collecting and purifying pentameric CRP that is produced by the transgenic silkworm constructed above.
First claim
Opening claim text (preview).
The invention claimed is: 1. An isolated nucleic acid sequence encoding canine monomeric C reactive protein (CRP), wherein said nucleic acid sequence encodes the amino acid sequence as set forth in SEQ ID NO: 1. 2. An isolated nucleic acid sequence encoding canine monomeric CRP, wherein the nucleic acid sequence is set forth over the entire length of the sequence set forth in SEQ ID NO: 4. 3. An expression vector comprising the isolated nucleic acid sequence of claim 1 . 4. The expression vector of claim 3 , wherein the isolated nucleic acid sequence is operably linked downstream of a UAS. 5. An expression vector comprising the isolated nucleic acid sequence of claim 2 . 6. The expression vector of claim 5 , wherein the isolated nucleic acid sequence is operably linked downstream of a UAS.
Assignees
Inventors
Classifications
Genetically modified invertebrates, e.g. transgenic or polyploid · CPC title
containing a signal sequence · CPC title
Insects, e.g. Drosophila melanogaster, medfly · CPC title
inducing gain of function · CPC title
- C07K14/4737Primary
C-reactive protein · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9359416B2 cover?
- Pentameric CRP is produced at a high efficiency by transferring DNA, which encodes monomeric CRP, into a silkworm to thereby construct a transgenic silkworm and then collecting and purifying pentameric CRP that is produced by the transgenic silkworm constructed above.
- Who is the assignee on this patent?
- Nitto Boseki Co Ltd, Nat Inst Of Agrobio Sciences
- What technology area does this patent fall under?
- Primary CPC classification C07K14/4737. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).